Načítá se...
Neoadjuvant immunotherapy combined with chemotherapy for local advanced non-small cell lung cancer: a case report
Immunotherapy has revolutionized lung cancer management and revitalized the field of tumor immunology. Anti-programmed death 1 (anti-PD-1) immunotherapy can significantly improve the survival of patients with advanced non-small cell lung cancer (NSCLC), but its role in neoadjuvant therapy of local a...
Uloženo v:
| Vydáno v: | Ann Transl Med |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
AME Publishing Company
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8106098/ https://ncbi.nlm.nih.gov/pubmed/33987422 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm-21-1565 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|